Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib

J Dermatol. 2024 Jan;51(1):e8-e10. doi: 10.1111/1346-8138.16945. Epub 2023 Sep 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • China
  • Collagen Type VII / genetics
  • Epidermolysis Bullosa Dystrophica* / complications
  • Epidermolysis Bullosa Dystrophica* / drug therapy
  • Epidermolysis Bullosa Dystrophica* / genetics
  • Genes, Recessive
  • Humans
  • Mutation
  • Pedigree
  • Phenotype

Substances

  • COL7A1 protein, human
  • Collagen Type VII
  • tofacitinib

Supplementary concepts

  • Epidermolysis Bullosa Pruriginosa